“…Aberrant expression of TGM2 [640], NEUROD1 [641], PRKG2 [642], RIT2 [324], TLR2 [643], MYRF (myelin regulatory factor) [642], SIRT2 [644], MMP3 [645], CASP1 [646], POU3F2 [647] and COMT (catechol-O-methyltransferase) [648] have been observed in HD. SERPINA1 [521], LRRK2 [649], TF (transferrin) [650], REN (renin) [651], TLR2 [652], MOBP (myelin associated oligodendrocyte basic protein) [653], SYK (spleen associated tyrosine kinase) [654], MBP (myelin basic protein) [625], SHH (sonic hedgehog signaling molecule) [655], RBP4 [590], SNCB (synuclein beta) [543], MMP3 [656], VWF (von Willebrand factor) [657], EGFR (epidermal growth factor receptor) [658], ABCA1 [659] and GPR39 [618] are associated with the clinical stages of dementia. Altered expression of LRRK2 [660], GPR17 [661], TF (transferrin) [662], NEUROD1 [663], RELN (reelin) [664], LCP1 [665], TFAP2B [666], HOXA5 [667], MSR1 [668], REN (renin) [669], OLIG2 [670], TLR2 [671], WT1 [672], SLC22A3 [673], CADM2 [674], PRKCH (protein kinase C eta) [675], MBP (myelin basic protein) [676], XAF1 [677], GPR37 [678], SHH (sonic hedgehog signaling molecule) [679], VTN (vitronectin) [680], SIRT2 [681], RBP4 [682], BMP2 [683], CDH13 [684], NR3C2 [685], TRPC6 [686], MMP3 [687], FGF19 [688], HLA-DRB1 [689], CD74 [690], VWF (von Willebrand factor) [691], ANGPT2 [692], CHRDL1 [693], AKR1C3 [694], NEDD4L [695], CASP1 [696], PDE2A [697], GAS7 [698], TET1 [699], EFNB2 [700], EGFR (epidermal growth factor receptor) [701<...…”